• OPEN AN ACCOUNT
Indian Indices
Sensex
76,835.78 776.01
( 1.02%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,889.11 277.96
(0.43%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Panyam Cements & Mineral Industries Ltd
Industry :  Cement - South India
BSE Code
ISIN Demat
Book Value()
500322
INE167E01037
-295.2772203
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PANYAMCEM
0
92.15
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Novartis India standalone net profit declines 13.82% in the March 2026 quarter
May 12,2026
Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales90.5583.88 8 354.33356.27 -1
OPM %22.7728.51 -26.5625.66 -
PBDT30.5634.42 -11 131.61132.61 -1
PBT30.1433.89 -11 129.66130.42 -1
NP25.2529.30 -14 93.18100.90 -8